United Therapeutics (UTHR) Capital Leases (2009)
United Therapeutics (UTHR) posted Capital Leases of $30.3 million for Q4 2009.
United Therapeutics (UTHR) Capital Leases (2009) Analysis & Trends
United Therapeutics has reported Capital Leases for 1 years, with the latest figure at $30.3 million in Q4 2009.
- Quarterly Capital Leases changed N/A year-over-year to $30.3 million in Q4 2009, while the trailing twelve-month figure through Dec 2009 was $30.3 million (changed N/A YoY) and the FY2009 annual result came in at $30.3 million, changed N/A from the prior year.
- Capital Leases held at $30.3 million in Q4 2009 per UTHR's latest filing.
- Over five years, Capital Leases peaked at $30.3 million in Q4 2009 and troughed at $30.3 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 30.33 Mn |